Acquisition Strategy Cantel Medical has been actively acquiring companies like Hu-Friedy and Omnia, signaling a growth strategy through expansion. Leveraging these new acquisitions can provide valuable cross-selling opportunities for the sales team to offer a wider range of infection prevention products and services to a broader customer base.
Technology Integration With a tech stack including Google Analytics, Microsoft, and jQuery, Cantel Medical demonstrates a commitment to leveraging technology for operational efficiency and customer insights. Sales development representatives can capitalize on this technological advantage to offer customized solutions and data-driven recommendations to healthcare providers, showcasing Cantel's innovative approach.
Financial Stability Despite recent legal inquiries, Cantel Medical's acquisition by STERIS for $4.6 billion indicates financial health and market confidence. This stability provides a strong foundation for sales professionals to build trust with customers, assuring them of Cantel's reliability and continuity in delivering quality infection prevention products and services.
Industry Positioning In an industry with similar companies like PerkinElmer, Danaher Corporation, and Thermo Fisher Scientific, Cantel Medical stands out as a leading player, showing competitive strength. Sales development representatives can emphasize Cantel's unique value proposition and product differentiation to capture market share and position the company as a preferred choice for healthcare providers.
Market Expansion Cantel Medical's recent acquisition by STERIS plc opens up opportunities for market expansion and collaboration. Sales professionals can leverage this strategic move to explore new partnership avenues, reach untapped customer segments, and drive sales growth by presenting a comprehensive portfolio of infection prevention solutions backed by two reputable companies.